• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大红十字会国家参考实验室的凝血因子VIII:C活性检测能力验证

Proficiency testing of factor VIII:C activity assays at the Canadian Red Cross Society National Reference Laboratory.

作者信息

Wasi S, Murray S A, Gill P

机构信息

National Reference Laboratory, Canadian Red Cross Society, Ottawa.

出版信息

Vox Sang. 1994;67(1):1-7. doi: 10.1111/j.1423-0410.1994.tb05028.x.

DOI:10.1111/j.1423-0410.1994.tb05028.x
PMID:7975443
Abstract

A national proficiency testing program has been established to monitor the accuracy and precision of factor VIII:C (FVIII:C) assays performed at the various Blood Services Centres of the Canadian Red Cross Society involved in the collection and processing of either donor blood designated for component production or plasma destined for fractionation. This paper describes the preparation, design, and results of the first four exercises involving 19 laboratories. The exercises were designed to allow the investigation of intralaboratory variability between replicate samples and precision of assays as well as the causes of interlaboratory variability. The implementation of this program has led to improved precision and interlaboratory agreement on FVIII:C assays. These improvements were achieved mainly as a result of a modification in the method for sample dilution, an increase in both replicate testing of the same sample and the number of sample dilutions, and a reduction in the number of reagent systems used by various centres.

摘要

已设立一项全国性能力验证计划,以监测加拿大红十字会各血液服务中心所进行的凝血因子VIII:C(FVIII:C)检测的准确性和精密度。这些中心参与采集和处理用于制备成分血的献血者血液或用于分馏的血浆。本文描述了涉及19个实验室的前四次检测的准备、设计和结果。这些检测旨在研究重复样本间的实验室内变异性和检测精密度,以及实验室间变异性的原因。该计划的实施提高了FVIII:C检测的精密度和实验室间的一致性。这些改进主要是由于样本稀释方法的改变、同一样本重复检测次数和样本稀释次数的增加,以及各中心使用的试剂系统数量的减少。

相似文献

1
Proficiency testing of factor VIII:C activity assays at the Canadian Red Cross Society National Reference Laboratory.加拿大红十字会国家参考实验室的凝血因子VIII:C活性检测能力验证
Vox Sang. 1994;67(1):1-7. doi: 10.1111/j.1423-0410.1994.tb05028.x.
2
Factor assay (VIII and IX) results in the College of American Pathologists Survey Program (1976-1979).美国病理学家学会调查项目(1976 - 1979年)中的凝血因子检测(VIII和IX)结果。
Scand J Haematol Suppl. 1980;37:116-29. doi: 10.1111/j.1600-0609.1980.tb01348.x.
3
Factor VIII assay variability in postinfusion samples containing full length and B-domain deleted FVIII.含有全长和B结构域缺失的FVIII的输注后样本中VIII因子检测的变异性。
Haemophilia. 2016 Sep;22(5):806-12. doi: 10.1111/hae.12962. Epub 2016 May 24.
4
Importance of a quality assurance scheme for factor VIII assays in quality monitoring of human plasma destined for fractionation into factor VIII concentrate.用于凝血因子VIII检测的质量保证方案在用于分馏制备凝血因子VIII浓缩物的人血浆质量监测中的重要性。
Vox Sang. 1989;56(2):65-70. doi: 10.1111/j.1423-0410.1989.tb04951.x.
5
Standardization of assays of factor VIII and factor IX.凝血因子 VIII 和凝血因子 IX 检测的标准化
Ric Clin Lab. 1990 Apr-Jun;20(2):155-65. doi: 10.1007/BF02877562.
6
Cap survey results for factor VIII assays (1977-1978).
Am J Clin Pathol. 1979 Aug;72(2 Suppl):346-51.
7
BAY 81-8973, a full-length recombinant factor VIII: results from an International comparative laboratory field study.BAY 81-8973,一种全长重组凝血因子VIII:一项国际比较实验室现场研究的结果
Haemophilia. 2016 May;22(3):e192-9. doi: 10.1111/hae.12925. Epub 2016 Mar 31.
8
Factor VIII test in reference preparations: compensation for different dilutions.
Pharmeur Sci Notes. 2005 Aug;2005(1):11-3.
9
[Comparison of factor VIII:C and factor IX sensitivity of different commercial APTT reagents for canine plasma].[不同商用活化部分凝血活酶时间(APTT)试剂对犬血浆中凝血因子VIII:C和凝血因子IX敏感性的比较]
Berl Munch Tierarztl Wochenschr. 1999 Oct-Nov;112(10-11):394-9.
10
Factors affecting the performance of factor VIII coagulant activity assays. Results of proficiency surveys of the College of American Pathologists.影响凝血因子 VIII 凝血活性检测性能的因素。美国病理学家学会能力验证调查结果。
Arch Pathol Lab Med. 1992 Sep;116(9):908-15.

引用本文的文献

1
Factor VIII and Factor IX Activity Measurements for Hemophilia Diagnosis and Related Treatments.VIII 因子和 IX 因子活性测定在血友病诊断及相关治疗中的应用。
Semin Thromb Hemost. 2023 Sep;49(6):609-620. doi: 10.1055/s-0042-1758870. Epub 2022 Dec 6.